[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @ClinOncNews ClinicalOncologyNews ClinicalOncologyNews posts on X about the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::524587400/interactions)  - X Week XX +37% - X Month XXX +203% - X Months XXXXX +372% - X Year XXXXX +107% ### Mentions: X [#](/creator/twitter::524587400/posts_active)  - X Week X +300% - X Month X +33% - X Months XX +500% - X Year XX +286% ### Followers: XXXXX [#](/creator/twitter::524587400/followers)  - X Week XXXXX -XXXX% - X Month XXXXX no change - X Months XXXXX +1.10% - X Year XXXXX no change ### CreatorRank: undefined [#](/creator/twitter::524587400/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) ### Top Social Posts Top posts by engagements in the last XX hours "The FDA approved epcoritamab-bysp (Epkinly Genmab US) with lenalidomide and rituximab for relapsed or refractory follicular lymphoma (FL)" [X Link](https://x.com/ClinOncNews/status/1992994213428879732) 2025-11-24T16:30Z 4217 followers, XXX engagements "The FDA approved selumetinib (Koselugo AstraZeneca) for adults with neurofibromatosis type X (NF1) who have symptomatic inoperable plexiform neurofibromas (PN)" [X Link](https://x.com/ClinOncNews/status/1998394763066691900) 2025-12-09T14:10Z 4218 followers, XX engagements "The FDA approved durvalumab (Imfinzi AstraZeneca) with FLOT chemotherapy as neoadjuvant and adjuvant treatment followed by single-agent durvalumab for adults with resectable gastric or gastroesophageal junction adenocarcinoma" [X Link](https://x.com/ClinOncNews/status/1998426314424906105) 2025-12-09T16:15Z 4218 followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@ClinOncNews ClinicalOncologyNewsClinicalOncologyNews posts on X about the most. They currently have XXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks
Top posts by engagements in the last XX hours
"The FDA approved epcoritamab-bysp (Epkinly Genmab US) with lenalidomide and rituximab for relapsed or refractory follicular lymphoma (FL)"
X Link 2025-11-24T16:30Z 4217 followers, XXX engagements
"The FDA approved selumetinib (Koselugo AstraZeneca) for adults with neurofibromatosis type X (NF1) who have symptomatic inoperable plexiform neurofibromas (PN)"
X Link 2025-12-09T14:10Z 4218 followers, XX engagements
"The FDA approved durvalumab (Imfinzi AstraZeneca) with FLOT chemotherapy as neoadjuvant and adjuvant treatment followed by single-agent durvalumab for adults with resectable gastric or gastroesophageal junction adenocarcinoma"
X Link 2025-12-09T16:15Z 4218 followers, XX engagements
/creator/twitter::ClinOncNews